Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
Bignon E, Alonso R, Arnone M, Boigegrain R, Brodin R, Gueudet C, Héaulme M, Keane P, Landi M, Molimard JC, Olliero D, Poncelet M, Seban E, Simiand J, Soubrié P, Pascal M, Maffrand JP, Le Fur G. Bignon E, et al. Among authors: arnone m. J Pharmacol Exp Ther. 1999 May;289(2):752-61. J Pharmacol Exp Ther. 1999. PMID: 10215649
Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.
Yendo TM, Sato MN, Branco ACCC, Pietrobon AJ, Teixeira FME, Ramos YÁL, Alberca RW, Valêncio CG, Arruda VN, Romiti R, Arnone M, Hirayama ALDS, Duarte AJDS, Aoki V, Orfali RL. Yendo TM, et al. Among authors: arnone m. Vaccines (Basel). 2021 May 10;9(5):478. doi: 10.3390/vaccines9050478. Vaccines (Basel). 2021. PMID: 34068473 Free PMC article.
Guselkumab: widened action in psoriatic disease.
Arnone M, Carvalho AVE, Fabricio LZ, Romiti R. Arnone M, et al. Clinics (Sao Paulo). 2021 May 5;76:e2629. doi: 10.6061/clinics/2021/e2629. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 33978074 Free PMC article. No abstract available.
165 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page